Actinium Pharmaceuticals Inc (ATNM)
1.7500 +0.2600 (+17.45%) 12:18 ET [NYSE Arca]
1.7400 x 100 1.7800 x 100
Realtime by (Cboe BZX)
1.7400 x 100 1.7800 x 100
Realtime 1.7300 +0.2400 (+16.11%) 09:28 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,677 | 109,306 | 78,221 | 63,608 | 9,302 |
| Marketable Securities | N/A | N/A | 50 | N/A | N/A |
| TOTAL | $78,263 | $110,942 | $79,749 | $64,925 | $10,088 |
| Non-Current Assets | |||||
| PPE Net | 550 | 604 | 340 | 312 | 113 |
| Investments And Advances | 0 | 0 | 0 | 50 | 50 |
| Other Non-Current Assets | 2,632 | 2,646 | 299 | 1,110 | 1,419 |
| TOTAL | $3,182 | $3,250 | $639 | $1,472 | $1,582 |
| Total Assets | $81,445 | $114,192 | $80,388 | $66,397 | $11,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,953 | 10,130 | 5,535 | 4,340 | 4,598 |
| TOTAL | $8,494 | $10,628 | $6,840 | $4,767 | $5,344 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 998 | N/A | N/A |
| aiOther Non-Current Liabilities | 1,553 | 2,083 | 0 | 245 | 531 |
| TOTAL | $36,572 | $37,083 | $3 | $311 | $682 |
| Total Liabilities | $45,066 | $47,711 | $6,843 | $5,078 | $6,026 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,396 | 25,729 | 22,144 | 19,246 | 10,101 |
| Common Shares | 28 | 26 | 22 | 18 | 5 |
| Retained earnings | -337,583 | -288,765 | -255,748 | -230,974 | -208,758 |
| TOTAL | $36,379 | $66,481 | $73,545 | $61,319 | $5,644 |
| Total Liabilities And Equity | $81,445 | $114,192 | $80,388 | $66,397 | $11,670 |